Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 at the interface of autophagosomes, endosomes and lysosomes
Dorien A. Roosen, Mark Cookson
Molecular Neurodegeneration (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

LRRK2 kinase in Parkinson's disease
Dario R. Alessi, Esther Sammler
Science (2018) Vol. 360, Iss. 6384, pp. 36-37
Open Access | Times Cited: 295
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi, Tomoki Kuwahara, Maria Sakurai, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 39
Open Access | Times Cited: 274
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
Rafeeq Mir, Francesca Tonelli, Paweł Lis, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1861-1883
Open Access | Times Cited: 193
The In Situ Structure of Parkinson’s Disease-Linked LRRK2
Reika Watanabe, Robert Buschauer, Jan Böhning, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1508-1518.e16
Open Access | Times Cited: 191
Mechanisms and roles of mitophagy in neurodegenerative diseases
Yan Wang, Na Liu, Bingwei Lu
CNS Neuroscience & Therapeutics (2019) Vol. 25, Iss. 7, pp. 859-875
Open Access | Times Cited: 190
Mitochondria and Parkinson’s Disease: Clinical, Molecular, and Translational Aspects
Max Borsche, Sandro L. Pereira, Christine Klein, et al.
Journal of Parkinson s Disease (2020) Vol. 11, Iss. 1, pp. 45-60
Open Access | Times Cited: 189
Mitophagy in Human Diseases
Laura Doblado, Claudia Lueck, Claudia Rey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3903-3903
Open Access | Times Cited: 168
Parkinson's Disease Genetics and Pathophysiology
Gabriel E. Vázquez-Vélez, Huda Y. Zoghbi
Annual Review of Neuroscience (2021) Vol. 44, Iss. 1, pp. 87-108
Open Access | Times Cited: 155
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
Sebastian Virreira Winter, Özge Karayel, Maximilian T. Strauss, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 3
Open Access | Times Cited: 118
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 110
Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
Jasmin Galper, Nicholas John Dean, Russell Pickford, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3472-3487
Open Access | Times Cited: 71
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Ho‐Su Lee, Evy Lobbestael, Séverine Vermeire, et al.
Gut (2020), pp. gutjnl-322429
Open Access | Times Cited: 125
Glial phagocytic clearance in Parkinson’s disease
Marie‐Ève Tremblay, Mark Cookson, Laura Civiero
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 124
Neuron-Astrocyte Interactions in Parkinson’s Disease
Ikuko Miyazaki, Masato Asanuma
Cells (2020) Vol. 9, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 119
LRRK2 and mitochondria: Recent advances and current views
Alpana Singh, Lianteng Zhi, Hui Zhang
Brain Research (2018) Vol. 1702, pp. 96-104
Open Access | Times Cited: 110
Sphingolipids in the Pathogenesis of Parkinson’s Disease and Parkinsonism
Guang Lin, Liping Wang, Paul C. Marcogliese, et al.
Trends in Endocrinology and Metabolism (2018) Vol. 30, Iss. 2, pp. 106-117
Closed Access | Times Cited: 110
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease
Kai-Jung Lin, Kai-Lieh Lin, Shang‐Der Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5312-5312
Open Access | Times Cited: 102
Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
Ga Ram Jeong, Eun-Hae Jang, Jae Ryul Bae, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 101
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
Jesús Madero‐Pérez, Elena Fdez, Belén Fernández, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 100
The effect of LRRK2 loss-of-function variants in humans
Nicola Whiffin, Irina M. Armean, Aaron Kleinman, et al.
Nature Medicine (2020) Vol. 26, Iss. 6, pp. 869-877
Open Access | Times Cited: 97
Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease
Nicoletta Plotegher, Michael R. Duchen
Frontiers in Cell and Developmental Biology (2017) Vol. 5
Open Access | Times Cited: 93
Dynamic control of the dopamine transporter in neurotransmission and homeostasis
Mengfei Bu, Matthew J. Farrer, Habibeh Khoshbouei
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong, Kelvin C. Luk, Kerry Purtell, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1406-1422
Open Access | Times Cited: 90
Page 1 - Next Page

Scroll to top